Guideline-based quality assurance: a conceptual framework for the definition of key elements.

Guidelines Healthcare quality Quality assurance Quality indicators Recommendations

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
24 Feb 2021
Historique:
received: 06 05 2020
accepted: 03 02 2021
entrez: 25 2 2021
pubmed: 26 2 2021
medline: 15 5 2021
Statut: epublish

Résumé

In 2017, the European Commission's Joint Research Centre (JRC) started developing a methodological framework for a guideline-based quality assurance (QA) scheme to improve cancer quality of care. During the first phase of the work, inconsistency emerged about the use of terminology for the definition, the conceptual underpinnings and the way QA relates to health questions that are answered in guidelines. The objective of this final of three articles is to propose a conceptual framework for an integrated approach to guideline and QA development and clarify terms and definitions for key elements. This work will inform the upcoming European Commission Initiative on Colorectal Cancer (ECICC). A multidisciplinary group of 23 experts from key organizations in the fields of guideline development, performance measurement and quality assurance participated in a mixed method approach including face-to-face dialogue and several rounds of virtual meetings. Informed by results of a systematic literature review that indicated absence of an existing framework and practical examples, we first identified the relations of key elements in guideline-based QA and then developed appropriate concepts and terminology to provide guidance. Our framework connects the three key concepts of quality indicators, performance measures and performance indicators integrated with guideline development. Quality indicators are constructs used as a guide to monitor, evaluate, and improve the quality of the structure, process and outcomes of healthcare services; performance measures are tools that quantify or describe measurable elements of practice performance; and performance indicators are quantifiable and measurable units or scores of practice, which should be guided by guideline recommendations. The inconsistency in the way key terms of QA are used and defined has confused the field. Our conceptual framework defines the role, meaning and interactions of the key elements for improving quality in healthcare. It directly builds on the questions asked in guidelines and answered through recommendations. These findings will be applied in the forthcoming ECICC and for the future updates of ECIBC. These are large-scale integrated projects aimed at improving healthcare quality across Europe through the development of guideline-based QA schemes; this will help in implementing and improving our approach.

Sections du résumé

BACKGROUND BACKGROUND
In 2017, the European Commission's Joint Research Centre (JRC) started developing a methodological framework for a guideline-based quality assurance (QA) scheme to improve cancer quality of care. During the first phase of the work, inconsistency emerged about the use of terminology for the definition, the conceptual underpinnings and the way QA relates to health questions that are answered in guidelines. The objective of this final of three articles is to propose a conceptual framework for an integrated approach to guideline and QA development and clarify terms and definitions for key elements. This work will inform the upcoming European Commission Initiative on Colorectal Cancer (ECICC).
METHODS METHODS
A multidisciplinary group of 23 experts from key organizations in the fields of guideline development, performance measurement and quality assurance participated in a mixed method approach including face-to-face dialogue and several rounds of virtual meetings. Informed by results of a systematic literature review that indicated absence of an existing framework and practical examples, we first identified the relations of key elements in guideline-based QA and then developed appropriate concepts and terminology to provide guidance.
RESULTS RESULTS
Our framework connects the three key concepts of quality indicators, performance measures and performance indicators integrated with guideline development. Quality indicators are constructs used as a guide to monitor, evaluate, and improve the quality of the structure, process and outcomes of healthcare services; performance measures are tools that quantify or describe measurable elements of practice performance; and performance indicators are quantifiable and measurable units or scores of practice, which should be guided by guideline recommendations.
CONCLUSIONS CONCLUSIONS
The inconsistency in the way key terms of QA are used and defined has confused the field. Our conceptual framework defines the role, meaning and interactions of the key elements for improving quality in healthcare. It directly builds on the questions asked in guidelines and answered through recommendations. These findings will be applied in the forthcoming ECICC and for the future updates of ECIBC. These are large-scale integrated projects aimed at improving healthcare quality across Europe through the development of guideline-based QA schemes; this will help in implementing and improving our approach.

Identifiants

pubmed: 33627092
doi: 10.1186/s12913-021-06148-2
pii: 10.1186/s12913-021-06148-2
pmc: PMC7903784
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

173

Références

SAGE Open Med. 2017 Jan 04;5:2050312116686516
pubmed: 28228948
Ann Intern Med. 2019 Aug 20;171(4):273-280
pubmed: 31330534
Implement Sci. 2016 Jan 15;11:6
pubmed: 26772173
Ann Intern Med. 2020 Jan 7;172(1):46-56
pubmed: 31766052
Syst Rev. 2018 Jan 12;7(1):5
pubmed: 29329578
Implement Sci. 2012 Mar 21;7:21
pubmed: 22436067
JAMA. 1988 Sep 23-30;260(12):1743-8
pubmed: 3045356

Auteurs

Elena Parmelli (E)

European Commission, Joint Research Centre (JRC), Via E. Fermi 2749 - TP 127, I-21027, Ispra, Italy. Elena.PARMELLI@ec.europa.eu.

Miranda Langendam (M)

Department of Epidemiology and Data Science, Amsterdam UMC, Amsterdam Public Health institute, University of Amsterdam, Amsterdam, Netherlands.

Thomas Piggott (T)

Department of Health Research Methods, Evidence, and Impact McMaster University Health Sciences Centre, Room 2C16, 1280 Main Street, West Hamilton, ON, L8N 4K1, Canada.

Jan Adolfsson (J)

Swedish Agency for Health Technology Assessment and Assessment of Social Services, Sweden & The Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Elie A Akl (EA)

American University of Beirut, Beirut, Lebanon.

David Armstrong (D)

Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Canada.
Department of Medicine, McMaster University, Hamilton, ON, Canada.

Jeffrey Braithwaite (J)

Australian Institute of Health Innovation, Macquarie University, Sydney, Australia.

Romina Brignardello-Petersen (R)

Department of Health Research Methods, Evidence, and Impact McMaster University Health Sciences Centre, Room 2C16, 1280 Main Street, West Hamilton, ON, L8N 4K1, Canada.

Markus Follmann (M)

German Cancer Society, Berlin, Germany.

Zbigniew Leś (Z)

Evidence Prime, Kraków, Poland.

Joerg J Meerpohl (JJ)

Institute for Evidence in Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Cochrane Germany, Cochrane Germany Foundation, Freiburg, Germany.

Luciana Neamtiu (L)

European Commission, Joint Research Centre (JRC), Via E. Fermi 2749 - TP 127, I-21027, Ispra, Italy.

Amir Qaseem (A)

American College of Physicians, Philadelphia, PA, USA.

Paolo Giorgi Rossi (PG)

Epidemiology Unit, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Zuleika Saz-Parkinson (Z)

European Commission, Joint Research Centre (JRC), Via E. Fermi 2749 - TP 127, I-21027, Ispra, Italy.

Philip J van der Wees (PJ)

Department of Rehabilitation and IQ Healthcare, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, Netherlands.

Holger J Schünemann (HJ)

Department of Health Research Methods, Evidence, and Impact McMaster University Health Sciences Centre, Room 2C16, 1280 Main Street, West Hamilton, ON, L8N 4K1, Canada. schuneh@mcmaster.ca.
Department of Medicine, McMaster University, Hamilton, ON, Canada. schuneh@mcmaster.ca.
Institute for Evidence in Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. schuneh@mcmaster.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH